HCA

$473.191.02%-4.89

Nachbörslich: 476.90+3.71 +0.78%

Hca Healthcare Inc (HCA)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$478.08

Offen:

$480.34

24-Stunden-Volumen:

1,116,860

Relatives Volumen:

0.79

Marktkapitalisierung:

$102.45B

Einnahmen:

$76.39B

Nettoeinkommen (Verlust:

$7.81B

KGV:

16.27

EPS:

$29.08

Netto-Cashflow:

$7.93B

1W Leistung:

+0.89%

1M Leistung:

+10.88%

6M Leistung:

+8.92%

1Y Leistung:

+1.37%

1-Tages-Spanne:

$472.46$485.73

1-Wochen-Bereich:

$439.83$488.00

52-Wochen-Spanne:

$353.99$556.52

Hca Healthcare Inc Aktie (HCA) Unternehmensprofil

Firmenname

Hca Healthcare Inc

Sektor

Healthcare

Branche

Medical Care Facilities

Telefon

(615) 344-9551

Adresse

ONE PARK PLZ, NASHVILLE, TN, USA

Mitarbeiter

320,000

@hcahealthcare

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

HCA-Diskussionen auf X

HCA vs. THC, EHC, DVA, FMS vergleichen

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HCA Hca Healthcare Inc	$473.19	$102.45B	$76.39B	$7.81B	$7.93B	$29.08
THC Tenet Healthcare Corp	$273.25	$22.00B	$21.46B	$2.65B	$3.35B	$19.23
EHC Encompass Health Corp	$135.90	$13.36B	$6.07B	$793.80M	$464.40M	$5.99
DVA Davita Inc	$187.50	$11.96B	$13.84B	$1.10B	$1.49B	$10.42
FMS Fresenius Medical Care Ag Adr	$22.47	$11.96B	$22.44B	$1.35B	$2.03B	$1.90

Hca Healthcare Inc Aktie (HCA) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-09-23	Eingeleitet	BMO Capital Markets	Outperform
2026-07-08	Herabstufung	Barclays	Overweight → Equal Weight
2025-12-15	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2025-10-14	Resumed	Goldman	Buy
2025-07-28	Herabstufung	Wolfe Research	Outperform → Peer Perform
2025-07-16	Herabstufung	BofA Securities	Buy → Neutral
2025-05-29	Hochstufung	Wells Fargo	Underweight → Equal Weight
2025-04-15	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-12-17	Resumed	JP Morgan	Neutral
2024-11-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2024-11-22	Herabstufung	Raymond James	Outperform → Mkt Perform
2024-10-11	Eingeleitet	KeyBanc Capital Markets	Overweight
2024-09-03	Eingeleitet	Morgan Stanley	Equal-Weight
2024-05-30	Eingeleitet	Robert W. Baird	Outperform
2024-03-06	Eingeleitet	Barclays	Overweight
2024-01-04	Herabstufung	Bernstein	Outperform → Mkt Perform
2023-12-11	Herabstufung	Goldman	Buy → Neutral
2023-04-21	Eingeleitet	Cantor Fitzgerald	Overweight
2023-04-19	Resumed	JP Morgan	Neutral
2022-07-06	Herabstufung	BMO Capital Markets	Market Perform → Underperform
2022-06-17	Eingeleitet	Loop Capital	Buy
2022-05-27	Hochstufung	Bernstein	Mkt Perform → Outperform
2022-03-29	Eingeleitet	Wells Fargo	Equal Weight
2022-01-10	Resumed	Citigroup	Buy
2021-12-21	Herabstufung	JP Morgan	Overweight → Neutral
2021-09-27	Eingeleitet	SVB Leerink	Outperform
2021-09-24	Eingeleitet	UBS	Buy
2021-09-10	Eingeleitet	Cowen	Outperform
2021-08-12	Herabstufung	Barclays	Overweight → Equal Weight
2021-07-09	Eingeleitet	Seaport Global Securities	Buy
2021-05-13	Resumed	Citigroup	Neutral
2021-04-26	Herabstufung	Citigroup	Buy → Neutral
2020-12-15	Eingeleitet	Goldman	Buy
2020-12-14	Hochstufung	JP Morgan	Neutral → Overweight
2020-09-21	Herabstufung	JP Morgan	Overweight → Neutral
2020-07-13	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2019-09-06	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-07-10	Hochstufung	Goldman	Neutral → Buy
2019-04-23	Hochstufung	Raymond James	Mkt Perform → Outperform
2019-01-14	Eingeleitet	Stephens	Overweight
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2018-11-16	Eingeleitet	UBS	Buy
2018-03-23	Resumed	Mizuho	Buy
2018-01-03	Eingeleitet	Goldman	Neutral
2018-01-03	Herabstufung	Piper Jaffray	Overweight → Neutral
2017-12-20	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2017-12-12	Hochstufung	Citigroup	Neutral → Buy
2017-11-30	Hochstufung	JP Morgan	Neutral → Overweight
2017-11-06	Bestätigt	Citigroup	Neutral
2017-11-01	Bestätigt	Mizuho	Buy
2017-07-26	Herabstufung	BofA/Merrill	Buy → Neutral
2017-06-28	Eingeleitet	Argus	Buy

Finanzdaten der Hca Healthcare Inc-Aktie (HCA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Hca Healthcare Inc-Aktie (HCA) Insiderhandel

McAlevey Michael RFeb 18 '26
EVP & Chief Legal & Admin Off.
Transaktion
Sale
Kosten
$533.37
#Aktien
1,694
Wert ($)
903,537
#Aktien Gesamt
8,853
Michael R McAleveyFeb 18 '26
OFFICER
Transaktion
Proposed Sale
Kosten
$533.34
#Aktien
1,694
Wert ($)
903,486
#Aktien Gesamt
0
McAlevey Michael RFeb 13 '26
EVP & Chief Legal & Admin Off.
Transaktion
Option Exercise
Kosten
$236.61
#Aktien
5,000
Wert ($)
1,183,050
#Aktien Gesamt
13,853
Berres JenniferFeb 11 '26
SVP & Chief Human Res. Officer
Transaktion
Sale
Kosten
$514.58
#Aktien
8,020
Wert ($)
4,126,950
#Aktien Gesamt
11,993
Jennifer L. BerresFeb 11 '26
OFFICER
Transaktion
Proposed Sale
Kosten
$514.58
#Aktien
8,020
Wert ($)
4,126,950
#Aktien Gesamt
0
Wyatt Christopher F.Feb 11 '26
SVP & Controller
Transaktion
Sale
Kosten
$505.00
#Aktien
4,000
Wert ($)
2,020,000
#Aktien Gesamt
44,379
Foster Jon MFeb 05 '26
EVP and COO
Transaktion
Option Exercise
Kosten
$139.06
#Aktien
29,330
Wert ($)
4,078,630
#Aktien Gesamt
29,330
Wyatt Christopher F.Feb 05 '26
SVP & Controller
Transaktion
Option Exercise
Kosten
$139.06
#Aktien
10,670
Wert ($)
1,483,770
#Aktien Gesamt
51,737
Cuffe Michael S.Feb 03 '26
EVP and Chief Clinical Officer
Transaktion
Sale
Kosten
$498.09
#Aktien
1,500
Wert ($)
747,135
#Aktien Gesamt
30,003
MICHAEL S CUFFEFeb 03 '26
OFFICER
Transaktion
Proposed Sale
Kosten
$498.09
#Aktien
1,500
Wert ($)
747,135
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
McAlevey Michael R	EVP & Chief Legal & Admin Off.	Feb 18 '26	Sale	$533.37	1,694	903,537	8,853
Michael R McAlevey	OFFICER	Feb 18 '26	Proposed Sale	$533.34	1,694	903,486	0
McAlevey Michael R	EVP & Chief Legal & Admin Off.	Feb 13 '26	Option Exercise	$236.61	5,000	1,183,050	13,853
Berres Jennifer	SVP & Chief Human Res. Officer	Feb 11 '26	Sale	$514.58	8,020	4,126,950	11,993
Jennifer L. Berres	OFFICER	Feb 11 '26	Proposed Sale	$514.58	8,020	4,126,950	0
Wyatt Christopher F.	SVP & Controller	Feb 11 '26	Sale	$505.00	4,000	2,020,000	44,379
Foster Jon M	EVP and COO	Feb 05 '26	Option Exercise	$139.06	29,330	4,078,630	29,330
Wyatt Christopher F.	SVP & Controller	Feb 05 '26	Option Exercise	$139.06	10,670	1,483,770	51,737
Cuffe Michael S.	EVP and Chief Clinical Officer	Feb 03 '26	Sale	$498.09	1,500	747,135	30,003
MICHAEL S CUFFE	OFFICER	Feb 03 '26	Proposed Sale	$498.09	1,500	747,135	0

Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten

Oct 29, 2026

HCA Healthcare Inc Stock (HCA) Moved Up by 3.07% on Oct 29: What Investors Need To Know - TradingKey

Oct 29, 2026

THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised - Zacks Investment Research

Oct 29, 2026

The 5 most interesting analyst questions from HCA Healthcare’s Q3 earnings call - Yahoo Finance

Oct 29, 2026

More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care - Business Wire

Oct 29, 2026

HCA Healthcare Reports Third Quarter 2026 Results - Florida Hospital News and Healthcare Report

Oct 29, 2026

Oct 28, 2026

HCA Healthcare Inc Stock (HCA) Moved Up by 3.18% on Oct 28: What Investors Need To Know - TradingKey

Oct 28, 2026

HCA’s bottom line suffers as ACA coverage losses mount - Healthcare Dive

Oct 28, 2026

HCA Healthcare: Payer Mix Pressures, But Broad Trends On Track (NYSE:HCA) - Seeking Alpha

Oct 28, 2026

HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results - Benzinga

Oct 28, 2026

Oct. 28 - HCA Healthcare, Inc., owner of Memorial Health Hospital posts Revenue Decline - Savannah Business Journal

Oct 28, 2026

Oct 27, 2026

HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 27, 2026

HCA CEO: Exchange Attrition Will Be a ’27 Problem, Too - HCI Innovation Group

Oct 27, 2026

HCA Healthcare, Inc. Stock 12‑Month Price Target Raised to $466.75 - TradingView

Oct 27, 2026

HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions - Zacks Investment Research

Oct 27, 2026

HCA Healthcare: Quarterly Revenue Up, but Net Income Down - marketscreener.com

Oct 27, 2026

HCA (HCA) Reports Q3 Earnings: What Key Metrics Have to Say - Zacks Investment Research

Oct 27, 2026

HCA Healthcare Profit Slips but Revenue Rises - WSJ

Oct 27, 2026

HCA Healthcare beats Q3 estimates, stock jumps By Investing.com - Investing.com Nigeria

Oct 27, 2026

HCA: Q3 Earnings Snapshot - WWLTV.com

Oct 27, 2026

RBC raises target for HCA Healthcare stock from USD 435 to USD 496 - ad-hoc-news.de

Oct 27, 2026

HCA Healthcare beats quarterly profit estimates on demand for medical services - Reuters

Oct 27, 2026

HCA Healthcare beats quarterly profit estimates on demand for medical services - Yahoo Finance Singapore

Oct 27, 2026

HCA Healthcare beats quarterly profit estimates on demand for medical services - Yahoo Finance

Oct 27, 2026

HCA Healthcare Reports Third Quarter 2026 Results - Business Wire

Oct 27, 2026